Durable responses and favorable cost‑effectiveness of rituximab‑based chemoimmunotherapy for primary cold agglutinin disease
10.1007/s44313-025-00109-y
- Author:
Kenichi ITO
1
;
Tomoko KITAGAWA
;
Saya MOTOHASHI
;
Kazuhiko HIRANO
;
Naohiro SEKIGUCHI
Author Information
1. Hematology Division, National Hospital Organization Disaster Medical Center, 3256 Midori‑Cho, Tachikawa, Tokyo 190‑0014, Japan
- Publication Type:CORRESPONDENCE
- From:Blood Research
2025;60():59-
- CountryRepublic of Korea
- Language:English
